Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for AspenBio Pharma, Inc. > News item |
AspenBio Pharma plans to sell common shares through public offering
Deal underwritten by Aegis, slated to fund general corporate purposes
By Devika Patel
Knoxville, Tenn., April 12 - AspenBio Pharma, Inc. plans to conduct a public offering of common stock, according to a Form S-1 filed Thursday with the Securities and Exchange Commission.
Aegis Capital Corp., the underwriter, has a 45-day greenshoe.
Proceeds will be used for general corporate purposes, including clinical trials.
AspenBio is a biopharmaceutical company based in Castle Rock, Colo.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.